drugset / Trial / NCT06190535

Can Administration of Etamsylate Reduce Postpancreatectomy Hemorrhage

NCT06190535

Unknown 20 enrolled University of Sfax
RandomizedParallel-groupDouble-blindPrevention

Summary

In several studies comparing the tow types of pancreato-digestive anastomosis: pancreatogastrostomy (PG) and pancreatojejunostomy (PJ), authors concluded that PG exposed to more postpancreatectomy hemorrhage (PPH) especially early, digestive and moderate hemorrhage classified as type A according to the classification of the ISGPS. In this way we try to test the ability of the enteral administration through the nasogastric tube of Etamsylate for 48 hours after Whipple to reduce the rate of digestive PPH and mortality.

Timeline

Start
2024-01-01
Primary completion
2024-12-31
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Etamsylate Unknown 500 mg Other

Indications